Nidan Laboratories and Healthcare (NSE:NIDAN) Interest Expense : ₹-20.9 Mil (TTM As of Mar. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Nidan Laboratories and Healthcare Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nidan Laboratories and Healthcare's interest expense for the six months ended in Mar. 2023 was ₹ -10.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was ₹-20.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nidan Laboratories and Healthcare's Operating Income for the six months ended in Mar. 2023 was ₹ 1.4 Mil. Nidan Laboratories and Healthcare's Interest Expense for the six months ended in Mar. 2023 was ₹ -10.6 Mil. Nidan Laboratories and Healthcare's Interest Coverage for the quarter that ended in Mar. 2023 was 0.13. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nidan Laboratories and Healthcare Interest Expense Historical Data

The historical data trend for Nidan Laboratories and Healthcare's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nidan Laboratories and Healthcare Interest Expense Chart

Nidan Laboratories and Healthcare Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-36.63

-33.64

-24.35

-20.95

-20.86

Nidan Laboratories and Healthcare Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24
Interest Expense	Get a 7-Day Free Trial			-17.19	-7.17	-10.32	-10.62	-

Nidan Laboratories and Healthcare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-20.9 Mil.

Nidan Laboratories and Healthcare (NSE:NIDAN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nidan Laboratories and Healthcare's Interest Expense for the six months ended in Mar. 2023 was ₹-10.6 Mil. Its Operating Income for the six months ended in Mar. 2023 was ₹1.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2023 was ₹47.7 Mil.

Nidan Laboratories and Healthcare's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2023 )	/	Interest Expense (Q: Mar. 2023 )
	=	-1	*	1.35	/	-10.624
	=	0.13

The higher the ratio, the stronger the company's financial strength is.

Nidan Laboratories and Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303

Website

https://www.nidanhealthcare.co.in

Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.

Nidan Laboratories and Healthcare Headlines

No Headlines